BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29284292)

  • 1. National Rare Diseases Registry System of China and Related Cohort Studies: Vision and Roadmap.
    Feng S; Liu S; Zhu C; Gong M; Zhu Y; Zhang S
    Hum Gene Ther; 2018 Feb; 29(2):128-135. PubMed ID: 29284292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innovation in Informatics to Improve Clinical Care and Drug Accessibility for Rare Diseases in China.
    Liu P; Gong M; Li J; Baynam G; Zhu W; Zhu Y; Chen L; Gu W; Zhang S
    Front Pharmacol; 2021; 12():719415. PubMed ID: 34721018
    [No Abstract]   [Full Text] [Related]  

  • 3. Rare Diseases: Joining Mainstream Research and Treatment Based on Reliable Epidemiological Data.
    Groft SC; Posada de la Paz M
    Adv Exp Med Biol; 2017; 1031():3-21. PubMed ID: 29214563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Rare Diseases Registry System (NRDRS): China's first nation-wide rare diseases demographic analyses.
    Guo J; Liu P; Chen L; Lv H; Li J; Yu W; Xu K; Zhu Y; Wu Z; Tian Z; Jin Y; Yang R; Gu W; Zhang S;
    Orphanet J Rare Dis; 2021 Dec; 16(1):515. PubMed ID: 34922584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare disease registries: a call to action.
    Lacaze P; Millis N; Fookes M; Zurynski Y; Jaffe A; Bellgard M; Winship I; McNeil J; Bittles AH
    Intern Med J; 2017 Sep; 47(9):1075-1079. PubMed ID: 28891182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pooling of manpower and resources through the establishment of European reference networks and rare disease patient registries is a necessary area of collaboration for rare renal disorders.
    Parker S
    Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv9-14. PubMed ID: 25165190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved Diagnosis and Care for Rare Diseases through Implementation of Precision Public Health Framework.
    Baynam G; Bowman F; Lister K; Walker CE; Pachter N; Goldblatt J; Boycott KM; Gahl WA; Kosaki K; Adachi T; Ishii K; Mahede T; McKenzie F; Townshend S; Slee J; Kiraly-Borri C; Vasudevan A; Hawkins A; Broley S; Schofield L; Verhoef H; Groza T; Zankl A; Robinson PN; Haendel M; Brudno M; Mattick JS; Dinger ME; Roscioli T; Cowley MJ; Olry A; Hanauer M; Alkuraya FS; Taruscio D; Posada de la Paz M; Lochmüller H; Bushby K; Thompson R; Hedley V; Lasko P; Mina K; Beilby J; Tifft C; Davis M; Laing NG; Julkowska D; Le Cam Y; Terry SF; Kaufmann P; Eerola I; Norstedt I; Rath A; Suematsu M; Groft SC; Austin CP; Draghia-Akli R; Weeramanthri TS; Molster C; Dawkins HJS
    Adv Exp Med Biol; 2017; 1031():55-94. PubMed ID: 29214566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a pilot rare disease registry: a focus group study of initial steps towards the establishment of a rare disease ecosystem in Slovenia.
    Stanimirovic D; Murko E; Battelino T; Groselj U
    Orphanet J Rare Dis; 2019 Jul; 14(1):172. PubMed ID: 31288838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National Registry of Designated Intractable Diseases in Japan: Present Status and Future Prospects.
    Kanatani Y; Tomita N; Sato Y; Eto A; Omoe H; Mizushima H
    Neurol Med Chir (Tokyo); 2017 Jan; 57(1):1-7. PubMed ID: 27666154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future of Rare Diseases Research 2017-2027: An IRDiRC Perspective.
    Austin CP; Cutillo CM; Lau LPL; Jonker AH; Rath A; Julkowska D; Thomson D; Terry SF; de Montleau B; Ardigò D; Hivert V; Boycott KM; Baynam G; Kaufmann P; Taruscio D; Lochmüller H; Suematsu M; Incerti C; Draghia-Akli R; Norstedt I; Wang L; Dawkins HJS;
    Clin Transl Sci; 2018 Jan; 11(1):21-27. PubMed ID: 28796445
    [No Abstract]   [Full Text] [Related]  

  • 11. Innovative measures to combat rare diseases in China: The national rare diseases registry system, larger-scale clinical cohort studies, and studies in combination with precision medicine research.
    Song P; He J; Li F; Jin C
    Intractable Rare Dis Res; 2017 Feb; 6(1):1-5. PubMed ID: 28357175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The RD-Connect Registry & Biobank Finder: a tool for sharing aggregated data and metadata among rare disease researchers.
    Gainotti S; Torreri P; Wang CM; Reihs R; Mueller H; Heslop E; Roos M; Badowska DM; de Paulis F; Kodra Y; Carta C; Martìn EL; Miller VR; Filocamo M; Mora M; Thompson M; Rubinstein Y; Posada de la Paz M; Monaco L; Lochmüller H; Taruscio D
    Eur J Hum Genet; 2018 May; 26(5):631-643. PubMed ID: 29396563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. China launched a pilot project to improve its rare disease healthcare levels.
    Cui Y; Zhou X; Han J
    Orphanet J Rare Dis; 2014 Jan; 9():14. PubMed ID: 24468030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized Medicine: What's in it for Rare Diseases?
    Schee Genannt Halfmann S; Mählmann L; Leyens L; Reumann M; Brand A
    Adv Exp Med Biol; 2017; 1031():387-404. PubMed ID: 29214584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The International LAM Registry: a component of an innovative web-based clinician, researcher, and patient-driven rare disease research platform.
    Nurok M; Eslick I; Carvalho CR; Costabel U; D'Armiento J; Glanville AR; Harari S; Henske EP; Inoue Y; Johnson SR; Lacronique J; Lazor R; Moss J; Ruoss SJ; Ryu JH; Seyama K; Watz H; Xu KF; Hohmann EL; Moss F
    Lymphat Res Biol; 2010 Mar; 8(1):81-7. PubMed ID: 20235890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare Disease Biospecimens and Patient Registries: Interoperability for Research Promotion, a European Example: EuroBioBank and SpainRDR-BioNER.
    Rubinstein YR; Posada de la Paz M; Mora M
    Adv Exp Med Biol; 2017; 1031():141-147. PubMed ID: 29214569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New and evolving rare diseases research programs at the National Institutes of Health.
    Groft SC; Rubinstein YR
    Public Health Genomics; 2013; 16(6):259-67. PubMed ID: 24503586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current views on rare diseases research and orphan drugs development].
    Jiang J; Li J; Liu W
    Sheng Wu Gong Cheng Xue Bao; 2011 May; 27(5):724-9. PubMed ID: 21845839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The European Paediatric Rare Tumours Network - European Registry (PARTNER) project for very rare tumors in children.
    Orbach D; Ferrari A; Schneider DT; Reguerre Y; Godzinski J; Bien E; Stachowicz-Stencel T; Surun A; Almaraz RL; Dragomir M; Jani D; Ami TB; Roganovic J; Brecht IB; Ladenstein R; Bisogno G
    Pediatr Blood Cancer; 2021 Jun; 68 Suppl 4():e29072. PubMed ID: 33913610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.